Immix Biopharma Inc Financial Flexibility Index
Immix Biopharma Inc financial flexibility index. Immix Biopharma Inc (IMMX) has a Financial Flexibility Index of -1.15x as of June 2026. Free cash flow of $-11.71 Million (operating CF $-11.74 Million minus capex $21.04K) represents -1% of total liabilities ($10.19 Million). See Immix Biopharma Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Immix Biopharma Inc (2019–2025)
Financial flexibility index of Immix Biopharma Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Immix Biopharma Inc across 7 annual periods. Explore debt repayment capacity of Immix Biopharma Inc to assess how comfortably operating cash covers total debt obligations.
Immix Biopharma Inc Financial Flexibility Index by Year (2019–2025)
Immix Biopharma Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Immix Biopharma Inc. For the full cash flow conversion analysis, see Immix Biopharma Inc (IMMX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.10x | $-23.20 Million | $-23.93 Million | $11.04 Million | ▼ -51.8% |
| 2024 | -1.38x | $-13.42 Million | $-14.60 Million | $9.70 Million | ▲ +54.5% |
| 2023 | -3.04x | $-11.32 Million | $-11.37 Million | $3.72 Million | ▲ +28.2% |
| 2022 | -4.24x | $-7.41 Million | $-7.41 Million | $1.75 Million | ▲ +46.1% |
| 2021 | -7.86x | $-1.59 Million | $-1.59 Million | $202.04K | ▼ -10139.0% |
| 2020 | -0.08x | $-404.69K | $-404.69K | $5.27 Million | ▲ +55.0% |
| 2019 | -0.17x | $-782.72K | $-790.03K | $4.59 Million | — |